The an anti-VEGF monoclonal antibody (mAb), Avastin® (bevacizumab), is an approved treatment for multiple types of cancers including lung, colon, glioblastoma, and renal-cell carcinoma [8]. This evidence concerns the gene VEGFA and cancer.